Atropine Sulfate
Product Images NDC 16729-526

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 16729-526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Atropine Sulfate (Atropine Structure)

Chemical structure of a compound consisting of a bicyclic ester linked to a benzyl group, shown as a dihydrate sulfate salt. The diagram includes atomic symbols and bonds illustrating the molecular arrangement.*

FDA Label Image

Principal Display Panel (Atropine Sulfate Injection, USP 0.4 mg/mL 1 Vial Carton)

Packaging label for Atropine Sulfate Injection, USP 0.4 mg/mL by Accord. The label indicates a sterile 1 mL single-dose vial for intravenous use. It includes NDC 16729-525-63, manufacturer details, dosage and storage information, and barcodes on a white background with magenta and black text accents.*

FDA Label Image

Principal Display Panel (Atropine Sulfate Injection, USP 0.4 mg/mL 10 Vials Carton)

Packaging label for Atropine Sulfate Injection, USP with a concentration of 0.4 mg/mL, supplied in 10 x 1 mL single-dose vials. The product is indicated for intravenous use and is sterile. It is manufactured for Accord Healthcare, Inc., Durham, NC, and by Intas Pharmaceuticals Limited, Ahmedabad, India. Storage instructions and dosage recommendations are included.*

FDA Label Image

Principal Display Panel (Atropine Sulfate Injection, USP 0.4 mg/mL 25 Vials Carton)

Packaging label for Atropine Sulfate Injection, USP 0.4 mg/mL by Accord. The label indicates 25 single-dose vials, each 1 mL, intended for intravenous use only. It includes storage instructions and manufacturing details, with NDC 16729-525-08 noted.*

FDA Label Image

Principal Display Panel (Atropine Sulfate Injection, USP 1 mg/mL 1 Vial Carton)

Packaging label for Atropine Sulfate Injection, USP, sterile, with a strength of 1 mg/mL. The label indicates a 1 mL single-dose vial for intravenous use, with instructions to discard unused portions. Manufacturer details reference Accord Healthcare, Inc. and Intas Pharmaceuticals Limited. Storage instructions specify 20°C to 25°C with permitted excursions, along with ingredient information and lot/expiration overcoding area.*

FDA Label Image

Principal Display Panel (Atropine Sulfate Injection, USP 1 mg/mL 10 Vials Carton)

Packaging label for Atropine Sulfate Injection, USP, 1 mg/mL, for intravenous use. The label states it contains 10 single-dose vials of 1 mL each. It indicates the product is sterile and for Rx only. Storage instructions specify 20°C to 25°C with permitted excursions. The label shows manufacturing information for Accord Healthcare, Inc. and Intas Pharmaceuticals Limited with barcodes present.*

FDA Label Image

Principal Display Panel (Atropine Sulfate Injection, USP 1 mg/mL 25 Vials Carton)

Packaging label for Atropine Sulfate Injection, USP, 1 mg/mL, intended for intravenous use. The box contains 25 single-dose vials of 1 mL each. The label includes NDC code 16729-526-08, states the product is sterile and prescription-only, and notes it is manufactured by Intas Pharmaceuticals Limited for Accord Healthcare, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.